Fubao Wang, PhD

Chief Regulatory & Technical Officer 

Dr. Wang joined Sardocor as CRO & CTO in August 2025. He has 28+ years of pharmaceutical and biotech industry experiences across multiple prophylactic and therapeutic areas and product modalities (Gene Editing, Cell & Gene Therapy, RNA Therapeutics, Biologics and Vaccines). His broad and in-depth product development and regulatory experiences include CMC, pre-clinical, early-stage and late-stage clinical development, global regulatory strategy, submission, approval and post-approval regulatory maintenance.

Dr. Wang served most recently as Senior Vice President, Head of Regulatory Affairs at Prime Medicine and AskBio. Prior to that, he served as Vice President, Head of Regulatory CMC at Sarepta Therapeutics, Associate Vice President, US site head of CMC Dossiers at Sanofi and Director of Global and Emerging Markets Regulatory Affairs at Merck (last position held). In these roles, he contributed to the development and/or regulatory approval of 50+ products (e.g., Dupixent, Elevidys, Vyondys and Amondys).

Dr. Wang holds B.S. in Biology and M.S. in Microbiology from Nankai University, China; Ph.D. in Molecular Biology from University of Heidelberg, Germany and was trained as a Post-Doctoral Fellow in Molecular Biology and Genetics at Stanford University, USA.